New lupus drug candidate enters early human testing

NCT ID NCT07011043

First seen Nov 01, 2025 · Last updated May 14, 2026 · Updated 27 times

Summary

This early-stage study is testing a new drug called budoprutug in 30 adults with active lupus who haven't responded well to other treatments. The main goal is to check if the drug is safe and how the body processes it. Researchers will also look for early signs that it might help control the disease.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SYSTEMIC LUPUS ERYTHEMATOSUS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Climb Bio Investigative Site #100101

    RECRUITING

    San Antonio, Texas, 78215, United States

  • Climb Bio Investigative Site #100103

    RECRUITING

    Caguas, Puerto Rico

  • Climb Bio Investigative Site #100104

    RECRUITING

    Allen, Texas, 75013, United States

  • Climb Bio Investigative Site #380101

    RECRUITING

    Ternopil, Ukraine

  • Climb Bio Investigative Site #380102

    RECRUITING

    Ivano-Frankivsk, Ukraine

  • Climb Bio Investigative Site #380103

    RECRUITING

    Kyiv, Ukraine

  • Climb Bio Investigative Site #380104

    RECRUITING

    Vinnytsia, Ukraine

  • Climb Bio Investigative Site #380105

    RECRUITING

    Vinnytsia, Ukraine

  • Climb Bio Investigative Site #380106

    RECRUITING

    Kyiv, Ukraine

  • Climb Bio Investigative Site #995101

    RECRUITING

    Tbilisi, 0141, Georgia

  • Climb Bio Investigative Site #995102

    RECRUITING

    Tbilisi, 0112, Georgia

  • Climb Bio Investigative Site# 300102

    RECRUITING

    Exochi, Thessaloniki, 57010, Greece

  • Climb Bio Investigative Site# 300103

    RECRUITING

    Thessaloniki, Thessaloniki, 54642, Greece

  • Climb Bio Investigative Site# 340101

    RECRUITING

    Sabadell, Barcelona, 08208, Spain

  • Climb Bio Investigative Site# 340102

    RECRUITING

    A Coruña, 15006, Spain

  • Climb Bio Investigative Site# 359101

    RECRUITING

    Plovdiv, 4002, Bulgaria

  • Climb Bio Investigative Site# 359102

    RECRUITING

    Sofia, 1618, Bulgaria

  • Climb Bio Investigative Site# 400101

    RECRUITING

    Cluj-Napoca, 400006, Romania

Conditions

Explore the condition pages connected to this study.